<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140000599A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140000599</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14003245</doc-number><date>20120316</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>M</subclass><main-group>16</main-group><subgroup>00</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>M</subclass><main-group>16</main-group><subgroup>14</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>M</subclass><main-group>16</main-group><subgroup>0051</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>M</subclass><main-group>16</main-group><subgroup>14</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>12820314</main-classification></classification-national><invention-title id="d0e43">SYSTEM AND METHOD OF REMOTELY MONITORING AND/OR MANAGING THE TREATMENT OF A PLURALITY OF SUBJECTS WITH AEROSOLIZED MEDICAMENT</invention-title><us-related-documents><us-provisional-application><document-id><country>US</country><doc-number>61453248</doc-number><date>20110316</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Dyche</last-name><first-name>Anthony</first-name><address><city>Hayling Island</city><country>GB</country></address></addressbook><residence><country>GB</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Rabbetts</last-name><first-name>Ian Philip</first-name><address><city>Hayling Island</city><country>GB</country></address></addressbook><residence><country>GB</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Denyer</last-name><first-name>Jonathan Stanley Harold</first-name><address><city>Chichester</city><country>GB</country></address></addressbook><residence><country>GB</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Dyche</last-name><first-name>Anthony</first-name><address><city>Hayling Island</city><country>GB</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Rabbetts</last-name><first-name>Ian Philip</first-name><address><city>Hayling Island</city><country>GB</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Denyer</last-name><first-name>Jonathan Stanley Harold</first-name><address><city>Chichester</city><country>GB</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>KONINKLIJKE PHILIPS N.V.</orgname><role>03</role><address><city>EINDHOVEN</city><country>NL</country></address></addressbook></assignee></assignees><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/IB12/51261</doc-number><kind>00</kind><date>20120316</date></document-id><us-371c124-date><date>20130905</date></us-371c124-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">Therapy regimes of a plurality of subjects are remotely monitored and/or managed, wherein the therapy regimes include reception of aerosolized medicament. This enables users such as medical care providers, researchers, clinic administrators, and/or other users to monitor and/or manage the therapy regimes of the plurality of subjects through a centralized access point. This reduces physical requirements of proximity for the users and/or the subjects, alleviates the administrative burden placed on the users to manage and/or monitor individual therapy regimes, and/or provides other enhancements over convention systems.</p></abstract></us-patent-application>